Skip to main content
. 2025 Apr 12;57(1):2491153. doi: 10.1080/07853890.2025.2491153

Table 3.

Odds ratios (or) of thyroid hormone sensitivity indices to histological characteristics in DTC patients.

  Thyroid hormone sensitivity indices
  FT3/FT4 TFQI
Outcome variables OR (95% CI) p value OR (95% CI) p value
Angioinvasion 1.49 (1.14, 1.94) .003 0.67 (0.47, 0.96) .028
Nerve invasion 0.81 (0.47, 1.40) .456 1.04 (0.60, 1.79) .901
Margin involvement 1.05 (0.94, 1.16) .401 1.09 (0.98, 1.22) .106
Lymph node metastases 1.16 (1.04, 1.29) .008 0.84 (0.75, 0.94) .002
Multifocal 1.02 (0.92, 1.14) .681 0.95 (0.85, 1.06) .385
Bilobar 0.95 (0.85, 1.08) .446 0.98 (0.87, 1.11) .727
Extrathyroidal invasion 1.01 (0.87, 1.17) .925 1.03 (0.88, 1.20) .757
Invasive pathological variants 1.38 (1.01, 1.89) .042 0.75 (0.39, 1.46) .401
Tumor size 0.35 (−0.06, 0.76) .094 0.26 (−0.13, 0.65) .195

The evaluation of the OR and 95% confidence interval (CI) was conducted using multivariable logistic regression models.

Adjusted model: adjusted for sex, age, BMI, TgAb-positive, TPOAb-positive, hashimoto thyroiditis.

DTC: differentiated thyroid cancer; FT3: free triiodothyronine; FT4: free thyroxine; TFQI: thyroid feedback quantile-based index; BMI: body mass index; TgAb: thyroglobulin antibody; TPOAb: thyroid peroxidase antibody.